The company is involved in the manufacturing and global marketing of a diverse range of pharmaceuticals both in India and internationally. Dr. Reddy’s Labs recently acquired MenoLabs from Amyris ...

The Nifty Pharma has gained around 37% year to date. The growth continues to be led by the US sales and well supported by ...

We have also seen Multinational companies (MNCs ... he was actively tracking US Pharma sector. He holds a medicine and management degree from premier institute in India. He has practiced as ...

Figure 1: Overall India pharma market growth (left ... the increase in promotional tie-ups between foreign and domestic companies to increase market penetration, how generic manufacturers can ...

The Indian biotechnology sector is a rapidly advancing segment within the economy, often referred to as a sunrise sector due ...

Lupin has announced a non-exclusive patent licence agreement with Takeda for the commercialisation of Vonoprazan Tablets in ...

In India, Lupin outpaced the market with an 18% YoY growth, significantly exceeding the Indian Pharmaceutical Market (IPM) growth rate of 8.7%. Additionally, the company recorded strong double ...

Lupin Limited partners with Takeda to launch Vonoprazan tablets in India, targeting acid peptic disorders with Lupivon brand.

The Indian pharma sector is flexing its muscles. In the last 12 months, the NSE Pharma has returned 50%, comfortably beating the Nifty that went up by 31%, while also returning an average 19% over ...

Elara Capital said that organic growth will be in the range of 11-14 per cent for pharma stocks but will fall short of our ...

DCGI suspends Entod Pharma`s eye drop permission for presbyopia treatment due to unapproved claims. The company will ...

Large pharmaceutical companies should support smaller companies ... 2024), organised by the Pharma Export Promotion Council of India (CAPEXIL) and the Ministry of Commerce and Industry, the ...